NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., Chief Executive Officer of Lev will present at the Cowen and Company 28th Annual Health Care Conference, being held March 17-20 at The Marriott Copley Place Hotel in Boston, MA. Dr. Schein will present a corporate progress report, including an update on the Company's lead product candidate, Cinryze™ (C1 inhibitor). The Lev presentation is scheduled to begin at 4:00 PM Eastern Time on Monday, March 17th.
